title: Modeling of PET data in CNS drug discovery and development.
abstract: Positron emission tomography (PET) is increasingly used in drug discovery and development for evaluation of CNS drug disposition and for studies of disease biomarkers to monitor drug effects on brain pathology. The quantitative analysis of PET data is based on kinetic modeling of radioactivity concentrations in plasma and brain tissue compartments. A number of quantitative methods of analysis have been developed that allow the determination of parameters describing drug pharmacokinetics and interaction with target binding sites in the brain. The optimal method of quantification depends on the properties of the radiolabeled drug or radioligand and the binding site studied. We here review the most frequently used methods for quantification of PET data in relation to CNS drug discovery and development. The utility of PET kinetic modeling in the development of novel CNS drugs is illustrated by examples from studies of the brain kinetic properties of radiolabeled drug molecules.
authors: Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. katarina.varnas@ki.se
authors: Katarina
authors: K
authors: Varnäs
authors: Andrea
authors: A
authors: Varrone
authors: Lars
authors: L
authors: Farde
mesh_terms: D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism*; D002491:Central Nervous System Agents / Q000097:blood / Q000493:pharmacokinetics*; D003198:Computer Simulation; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D008954:Models, Biological; D049268:Positron-Emission Tomography / Q000379:methods*; D014018:Tissue Distribution
chemical_list: D002491:Central Nervous System Agents
references: Acta Neurol Scand. 2002 Dec;106(6):325-32
references: 12460136
references: J Cereb Blood Flow Metab. 1990 Sep;10(5):740-7
references: 2384545
references: Psychopharmacology (Berl). 1995 May;119(1):1-8
references: 7675940
references: Drug Metab Dispos. 2007 Sep;35(9):1711-9
references: 17591680
references: J Nucl Med. 2001 May;42(5):755-63
references: 11337572
references: Mol Imaging Biol. 2003 Nov-Dec;5(6):363-75
references: 14667491
references: Adv Drug Deliv Rev. 2011 Jun 19;63(7):539-46
references: 20887762
references: J Cereb Blood Flow Metab. 2011 Jan;31(1):113-23
references: 20424633
references: J Pharmacol Exp Ther. 2006 Jan;316(1):410-22
references: 16183706
references: Nat Rev Drug Discov. 2003 Mar;2(3):233-40
references: 12612650
references: Psychopharmacology (Berl). 1989;99(1):8-12
references: 2528781
references: Clin Pharmacol Ther. 2006 Sep;80(3):203-15
references: 16952487
references: Clin Pharmacokinet. 2002;41(8):581-602
references: 12102642
references: Nucl Med Biol. 2004 Feb;31(2):165-71
references: 15013481
references: J Nucl Med. 2010 Sep;51(9):1331-4
references: 20720060
references: Arch Gen Psychiatry. 1988 Jan;45(1):71-6
references: 2892477
references: Drug Metab Dispos. 2009 Jul;37(7):1548-56
references: 19389861
references: J Neurosci. 1987 Aug;7(8):2373-89
references: 3612246
references: J Cereb Blood Flow Metab. 2010 Jan;30(1):46-50
references: 19738632
references: Clin Pharmacokinet. 2011 Feb;50(2):111-20
references: 21142292
references: Eur Neuropsychopharmacol. 1997 Aug;7(3):195-200
references: 9213078
references: Biol Psychiatry. 1993 Feb 15;33(4):227-35
references: 8097114
references: J Cereb Blood Flow Metab. 2012 May;32(5):874-83
references: 22274741
references: Drug Metab Dispos. 2005 Jan;33(1):175-81
references: 15502010
references: Am J Psychiatry. 2004 May;161(5):826-35
references: 15121647
references: Acta Psychiatr Scand Suppl. 1990;358:67-71
references: 1978494
references: J Cereb Blood Flow Metab. 2002 Oct;22(10):1271-81
references: 12368666
references: J Cereb Blood Flow Metab. 1989 Oct;9(5):696-708
references: 2528555
references: Neurology. 1983 May;33(5):580-5
references: 6601779
references: Neuroimage. 2012 Jun;61(2):505-16
references: 22173295
references: J Neurol Sci. 2011 Nov 15;310(1-2):40-3
references: 21840542
references: J Cereb Blood Flow Metab. 2003 Sep;23(9):1096-112
references: 12973026
references: Nucl Med Biol. 2000 Jan;27(1):43-9
references: 10755644
references: J Nucl Med. 2000 Dec;41(12):2083-8
references: 11138696
references: Psychopharmacology (Berl). 2002 Dec;164(4):341-8
references: 12457263
references: J Cereb Blood Flow Metab. 1996 Sep;16(5):834-40
references: 8784228
references: Neurology. 1993 Oct;43(10):1984-92
references: 8413955
references: Psychopharmacology (Berl). 2003 Apr;167(1):37-45
references: 12632244
references: J Cereb Blood Flow Metab. 1996 Jan;16(1):42-52
references: 8530554
references: J Nucl Med. 2008 Aug;49(8):1328-35
references: 18632828
references: Nucl Med Biol. 2001 Jul;28(5):595-608
references: 11516703
references: J Cereb Blood Flow Metab. 1993 Jan;13(1):24-42
references: 8380178
references: Am J Physiol. 1959 Dec;197:1205-10
references: 14437359
references: Arch Gen Psychiatry. 1990 Mar;47(3):213-9
references: 1968328
references: Neuropsychopharmacology. 2003 Nov;28(11):2000-9
references: 12902992
references: Science. 1987 Jan 23;235(4787):481-5
references: 3099392
references: Arch Pharm Res. 2012 Sep;35(9):1591-7
references: 23054716
references: J Nucl Med. 2009 Aug;50(8):1267-75
references: 19617341
references: J Cereb Blood Flow Metab. 2000 Jul;20(7):1111-33
references: 10908045
references: Nucl Med Biol. 1997 Aug;24(6):507-11
references: 9316077
references: Ann Nucl Med. 2008 Jan;22(1):1-11
references: 18250982
references: J Nucl Med. 1998 Jan;39(1):208-14
references: 9443763
references: Clin Pharmacol Ther. 2009 May;85(5):506-12
references: 19129751
references: Mol Imaging Biol. 2005 Nov-Dec;7(6):377-87
references: 16265597
references: Proc Natl Acad Sci U S A. 1985 Jun;82(11):3863-7
references: 3873656
references: Trends Pharmacol Sci. 2006 Jun;27(6):310-6
references: 16678917
references: Neuroimage. 2009 Jul 1;46(3):616-23
references: 19286462
references: Bioorg Med Chem Lett. 2012 Nov 15;22(22):6974-9
references: 23046966
references: Neuropsychopharmacology. 2000 Apr;22(4):422-9
references: 10700661
references: J Nucl Med. 2010 Apr;51(4):559-66
references: 20237038
references: Expert Opin Drug Metab Toxicol. 2008 Dec;4(12):1499-506
references: 19040326
references: J Cereb Blood Flow Metab. 1986 Apr;6(2):137-46
references: 2937794
references: J Cereb Blood Flow Metab. 2001 Jun;21(6):635-52
references: 11488533
references: Bioorg Med Chem Lett. 2002 Feb 11;12(3):295-8
references: 11814781
references: Trends Pharmacol Sci. 2009 Aug;30(8):431-40
references: 19616318
references: Eur J Pharm Sci. 2010 May 12;40(2):125-31
references: 20307657
references: Int J Neuropsychopharmacol. 2009 Sep;12(8):1021-32
references: 19236731
references: Eur J Pharmacol. 1999 Mar 5;368(2-3):161-72
references: 10193652
references: Pharmacol Ther. 2009 Jun;122(3):281-301
references: 19306894
references: Ann Neurol. 1984 Mar;15(3):217-27
references: 6609679
references: Clin Pharmacol Ther. 2006 Sep;80(3):216-27
references: 16952488
references: Science. 1986 Jan 17;231(4735):258-61
references: 2867601
references: J Pharmacol Exp Ther. 2010 Jan;332(1):17-25
references: 19779131
references: Xenobiotica. 2008 Dec;38(12):1518-35
references: 18979396
references: Neuroimage. 1996 Dec;4(3 Pt 1):153-8
references: 9345505
references: Psychopharmacology (Berl). 2011 Feb;213(2-3):533-45
references: 21234549
references: J Pharmacol Exp Ther. 2005 Jan;312(1):309-15
references: 15347732
references: J Cereb Blood Flow Metab. 1991 Jul;11(4):545-56
references: 1904879
references: Neuroimage. 2006 Oct 1;32(4):1690-708
references: 16859930
references: Q J Nucl Med Mol Imaging. 2012 Feb;56(1):68-82
references: 22460161
references: Lancet Neurol. 2010 Apr;9(4):363-72
references: 20189881
references: J Cereb Blood Flow Metab. 1991 Sep;11(5):735-44
references: 1651944
references: Eur J Clin Pharmacol. 2003 Sep;59(5-6):357-66
references: 12937873
references: Acta Physiol Scand. 1963 Aug;58:292-305
references: 14078649
references: Nat Rev Drug Discov. 2010 Dec;9(12):929-39
references: 21119731
references: Pharm Res. 2008 Aug;25(8):1737-50
references: 18058202
references: CNS Neurosci Ther. 2011 Apr;17(2):97-103
references: 21143431
references: J Cereb Blood Flow Metab. 2013 Mar;33(3):407-14
references: 23211960
references: Arch Gen Psychiatry. 2003 Apr;60(4):386-91
references: 12695316
references: J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9
references: 17519979
references: J Clin Psychopharmacol. 2006 Apr;26(2):188-91
references: 16633150
references: J Pharmacol Exp Ther. 1984 Jul;230(1):250-5
references: 6611397
references: Neuroimage. 2012 Jul 16;61(4):849-56
references: 22425672
references: J Pharmacol Exp Ther. 1996 Oct;279(1):325-31
references: 8859010
references: Ann Neurol. 2004 Mar;55(3):306-19
references: 14991808
references: Brain. 1990 Feb;113 ( Pt 1):27-47
references: 2302536